Febbo Phillip G. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$2.16M

Insider Activity of Febbo Phillip G.

According to the SEC Form 4 filings, Febbo Phillip G., being in a position of

  1. Chief Scientific & Med Officer at Veracyte, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 26535 shares for $1.05M,
    over all time since 2024-12-04, has bought 0 shares, and sold 46855 shares for $1.79M.

Biography of Febbo Phillip G.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,049,8392100

Comparison of Insiders on Amount of Buys and Sells

2026-09-04SaleVeracyte, Inc.
VCYT
Chief Scientific & Med Officer
13,110
0.0166%
$43.05$564,410+4.37%
2026-03-02SaleVeracyte, Inc.
VCYT
Chief Scientific & Med Officer
13,425
0.0168%
$36.16$485,429+22.24%
2025-10-06SaleVeracyte, Inc.
VCYT
Chief Scientific & Med Officer
8,349
0.0106%
$36.02$300,709+16.65%
2025-03-04SaleVeracyte, Inc.
VCYT
Chief Scientific & Med Officer
8,037
0.0102%
$33.35$268,013-5.78%
2024-12-04SaleVeracyte, Inc.
VCYT
Chief Scientific & Med Officer
3,934
0.0051%
$44.09$173,447-27.24%
2022-04-05SaleIllumina, Inc.
ILMN
SVP Chief Medical Officer
1,988
0.0013%
$360.01$715,700-41.78%
2021-11-08SaleIllumina, Inc.
ILMN
SVP Chief Medical Officer
1,000
0.0006%
$406.83$406,830-38.63%
2021-06-11SaleIllumina, Inc.
ILMN
SVP Chief Medical Officer
1,000
0.0007%
$447.59$447,589-16.28%
2020-11-06SaleIllumina, Inc.
ILMN
SVP Chief Medical Officer
155
0.0001%
$310.10$48,066+34.2%
2020-04-16SaleIllumina, Inc.
ILMN
SVP Chief Medical Officer
173
0.0001%
$300.00$51,900+18.16%
2019-11-14SaleIllumina, Inc.
ILMN
SVP Chief Medical Officer
155
0.0001%
$300.00$46,500+8.17%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.